RESUMO
BACKGROUND: Lapidus arthrodesis is one of the most commonly used techniques in the correction of moderate and severe hallux valgus. We analyzed the clinical and radiological outcomes after using the Phantom® Lapidus intramedullary nail to find an effective technique with low complications. METHODS: We retrospectively analyzed data of 52 patients who underwent a modified Lapidus arthrodesis with an intramedullary nail at our center from November 2019 to September 2022. The mean follow-up period was 27 (range, 18-34) months. Clinical results were evaluated using the visual analog scale (VAS), the European Foot and Ankle Society score (EFAS) and the American Orthopaedic Foot and Ankle Society score (AOFAS); three different radiological measures were analyzed. RESULTS: The mean AOFAS score increased from 44.8 to 82 points. The mean EFAS score increased from 11.2 to 20.1 points. The mean VAS score decreased by 4.7 points. The mean EFAS Sport score was increased from 9.2 (SD 4.6) to 12.6 (SD 5.4) points. The intermetatarsal angle decreased from 15° to 6.9° and the hallux valgus angle by a mean of 17.9°. The forefoot width reduced from 93.6 to 84.7 mm. All results were statistically significant (p < .001). One case of nonunion was recorded. No implant-related complications were observed. CONCLUSIONS: This device was effective in correcting moderate to severe hallux valgus, with significant patient satisfaction. Its complication rate was not higher than that of other fixation devices. Correct compression of the arthrodesis, absence of extraosseous material, and multidirectional stability are important qualities of this implant for the correct treatment of this pathology. LEVEL OF EVIDENCE: Level IV, retrospective case series.
RESUMO
Objetivos: Determinar la frecuencia de síntomas depresivos en pacientes con Trastorno por déficit de atención con hiperactividad (TDAH), así como determinar su asociación con edad, sexo y comorbilidad psiquiátrica. Material y Método: Se realizó un estudio descriptivo de corte transversal. Se incluyeron pacientes con diagnóstico de TDAH del Instituto Nacional de Salud Mental Honorio Delgado Hideyo Noguchi, desde febrero del 2006 hasta completar el tamaño de la muestra. Se les aplicó a los pacientes el Children´s depression inventory (CDI). Se consideró un punto de corte de 15 para definir presencia de trastorno depresivo. Se analizaron las siguientes variables: edad, sexo, comorbilidad psiquiátrica y sintomatología depresiva. Resultados: Sesenta y cuatro (85,3%) fueron varones, en 35/75 (46,7%) se encontró CDI ³ 15. No se encontró asociación estadísticamente significativa entre síntomas depresivos y sexo o edad. El síntoma depresivo más frecuente fue el problema del rendimiento escolar (65,3%). Se encontraron 6 pacientes con otra comorbilidad. Conclusión: Existe una alta frecuencia de sintomatología depresiva en niños y adolescentes con diagnóstico de TDAH. (AU) .
Objectives: To determine the frequency of depressive symptoms in patients between 7 and 17 years diagnosed of Attention-Deficit/Hyperactivity Disorder (ADHD), and determine the association between depressive symptoms with age, sex and psychiatric comorbidity. Material and Method: A descriptive, cross sectional study was made. Patients diagnosed of ADHD of the Specialized Institute of Mental Health Hideyo Noguchi were recruited from February 2006 until completion of size sample. Children´s depression inventory (CDI) was applied. It was considered a cutoff point of 15 to define the presence of depressive disorder. We analyzed the following variables: age, sex, psychiatric comorbidity and depressive symptoms. Results: 64 (85.3%) were men, 35/75 patients (46.7%) obtained scores of 15 or more in the CDI. We did not find association between depressive symptoms and sex or age. The most frequent depressive symptom was related to school performance (65.3%). There were only 6 patients with other comorbidity. Conclusion: There is a very high frequence of depressive symptoms in children diagnosed with ADHD, there should be more studies made to analyse association between these two clinical entities. (AU).